Master-clinician ratio
Residence capacity
Staff-bound discretion
Part 2 protections
Spa-style amenities are easy to copy. What separates a serious integrative program from a luxury wellness brand are four clinical decisions that change outcomes — not aesthetics.
Most residential programs rely on bachelor's-level counselors with a single supervising MD. We staff master's and doctoral clinicians at a one-to-one resident ratio, with a board-certified addiction medicine physician on site daily. The difference is visible in the diagnostic depth — the dual-diagnosis case missed by standard intake is the case we are equipped to find.
Intake is two days, not two hours. We use the full ASAM Criteria assessment, validated trauma screens, comprehensive psychiatric evaluation, and complete bloodwork. Roughly forty percent of the adults we admit have an unrecognized co-occurring condition — trauma, hypothyroid, sleep disorder, sub-clinical depression — that standard intakes overlook and that derails recovery in the third week if untreated.
Cognitive behavioral therapy, dialectical behavior therapy, EMDR, motivational interviewing, and medication-assisted treatment form the clinical spine. Around them we add somatic experiencing, equine therapy, mindfulness-based relapse prevention, and nutrition psychiatry — modalities with their own research base, integrated as supplements rather than substitutes.
HIPAA and 42 CFR Part 2 set the floor. We add NDA-bound clinical and household staff, an undisclosed residence address, no photographs, no social media, no published discharge dates. A press-handling protocol exists in writing. If you are recognizable, this is the protection your reputation requires.
The word “addiction” covers conditions that need opposite responses. Two of the withdrawals below can be fatal without medical supervision; two cannot. Which one you are dealing with decides everything that follows, and it is the first thing established on the call.
One of only two withdrawals that can kill on its own. Daily drinking that has continued for months is a medical situation before it is anything else, and the assessment comes before any decision to stop. Alcohol treatment →
Nearly everyone who takes them regularly beyond a month becomes physically dependent; only about 1.5% develop a use disorder. Being unable to stop is the expected pharmacology, not a character finding. Dependence and tapering →
The one class with medications proven to reduce death. Detox alone, without medication to follow, raises the risk of a fatal overdose rather than lowering it — which is why the plan matters more than the willpower. Prescription and illicit opioids →
Stimulants, sleep medicines and nerve-pain drugs are three separate problems with three separate treatments. You can meet the clinical criteria without ever exceeding the dose on the label. Stimulants, sleep and nerve medicines →
No medication is approved for stimulant use disorder, so the treatment is behavioural and specific — and the difference between programmes that run the evidence-based version and those that do not is worth asking about directly. Cocaine treatment →
Work intact, family intact, reputation intact — and a pattern that has quietly stopped being optional. This is the most common way our admissions conversations begin. The high-functioning pattern →
“Nearly all patients who take benzodiazepines regularly for more than a month will develop physical dependence, while only 1.5% will develop a benzodiazepine use disorder.”
American Society of Addiction Medicine and nine partner societies — Joint Clinical Practice Guideline on Benzodiazepine Tapering, 2025We quote a guideline rather than a patient. Recovery is not a testimonial industry, and a programme that publishes glowing quotes from people whose privacy it is meant to protect has already told you something.
Most people who call assume treatment means disappearing for thirty days. For a substantial share of them it does not. The levels below run from most to least intensive; the honest recommendation is the least intensive one that is clinically sufficient.
Supervised withdrawal where stopping carries physical risk — alcohol, benzodiazepines, and any combination involving them. Days, not weeks, and it is a beginning rather than a treatment.
Living on site with clinical staff present around the clock. Indicated when the home environment is itself part of the problem, or when previous outpatient attempts have not held.
Close to full-time clinical hours while sleeping at home. ASAM now calls this level high-intensity outpatient, which describes it more accurately than the older name did.
Nine or more clinical hours a week, arranged around work. This is the level most often right for someone whose life is still functioning and who intends to keep it that way.
Regular individual and group sessions without the weekly hour load. Usually a step down after something more intensive, occasionally the right entry point on its own.
Buprenorphine, methadone or naltrexone alongside therapy, for opioid and alcohol use disorder. Federal agencies increasingly call it medication for opioid use disorder, for a reason worth understanding.
The Cochrane evidence supports a specific clinical method of connecting people to these groups — not the advice to simply attend one. The distinction changes the outcome.
No questionnaire to fill in. No web form that auto-emails a sales coordinator. The first conversation is by phone with a clinician.
Twenty-five minutes with our admissions clinician. We ask about substances, sleep, family, and what brought you here this week. No sales script. We will tell you if Peninsula is the wrong fit and recommend somewhere we believe is.
If we proceed, a two-day intake — psychiatric evaluation, full bloodwork, ASAM-Criteria assessment, validated trauma and mood screens. A personalized program is built from this, not from a brochure tier.
Private transport from any major airport. A clinician greets you. The press-handling and family-communication protocol is reviewed and signed before your first session.
A small collection of essays on the questions executives and their families ask most often — written by our clinical leadership, reviewed by the editorial team.
Answered the way we would answer them on the phone, including where the answer is “it depends” and what it depends on.
Usually not. Residential treatment is one level of care among several, and for a large share of the people who call it is not the clinically indicated one. Partial hospitalization and intensive outpatient deliver serious clinical hours while you sleep at home and, in many cases, keep working.
The honest recommendation is the least intensive level that is clinically sufficient — not the most expensive one available. If residential is genuinely indicated we will say so and explain why; if it is not, we will say that too.
For two classes, yes. Alcohol and benzodiazepines — including the Z-drugs such as Ambien and Lunesta — can produce withdrawal seizures that are life-threatening. Gabapentin and pregabalin have produced withdrawal seizures in published case reports. Opioid withdrawal is severe but rarely fatal on its own, and stimulant withdrawal is not physically dangerous.
If any of the first group is on your list, the first step is an assessment, not a decision to stop. This is the single most common way people are hurt by acting on good intentions.
A clinician answers — not a call centre, and not a salesperson working from a script. About twenty-five minutes. We ask what you are taking, how much, for how long, what else is on the list, and what you have already tried.
Nothing is entered anywhere, no intake form is required, and there is no email follow-up unless you ask for one. If the right answer is that you need a prescriber rather than a programme, that is what you will be told; it is a short call and a common outcome.
No, and for many people the label is clinically wrong as well as unwelcome. Physical dependence and a use disorder are different conditions: nearly everyone on a benzodiazepine beyond a month becomes dependent, while only about 1.5% develop a use disorder. Among adults meeting the criteria for prescription stimulant use disorder, 42.5% reported no misuse at all.
Treatment is organised around what is actually happening, not around getting you to accept a description of yourself.
Substance use treatment records carry protection beyond HIPAA under 42 CFR Part 2, a federal rule written specifically for this category of care. In practice it means your records cannot be disclosed the way ordinary medical records sometimes can.
Beyond the legal floor: no photography on site, no social media, no published discharge dates, and a press-handling protocol agreed in writing before admission where recognisability is a concern.
More is covered than most people expect. Federal parity law requires plans that cover substance use treatment to do so on terms comparable to medical and surgical care, so assessment, withdrawal management, outpatient and structured outpatient programmes are ordinarily covered in-network.
What is generally not covered at the advertised rate is the private-residential end — the room, the setting, the amenities. The number to establish before committing is not the sticker price but your out-of-pocket maximum for the plan year and how much of it is already spent. Our full breakdown is in does insurance cover rehab.
It depends entirely on the substance, and the difference is large. Opioid use disorder has three FDA-approved medications with evidence that they reduce death. Alcohol use disorder has approved options as well. For stimulants, sedatives and gabapentinoids there is no approved medication — for stimulants the strongest evidence sits with a specific behavioural treatment, and for sedatives the taper itself is the treatment.
A programme that offers one answer for all four is describing a product rather than a clinical plan.
Most search results for treatment are lead brokers who sell your enquiry to whichever facility has an open bed. Five questions separate them, and all five can be asked on a first call: which drug class am I dealing with and how does that change your plan; who writes the taper and can it be slowed; what happens to my ADHD, insomnia or pain during and after; is contingency management offered and on what schedule; and am I speaking to clinical staff or a call centre.
You are not testing knowledge. You are testing whether the person is describing a clinical process or selling a place.
Only to the degree you decide. Family involvement improves outcomes in most of the evidence, and it is offered rather than imposed. Where a partner or parent is the person reading this instead, the same first call applies: twenty-five minutes with a clinician, no commitment, and a realistic account of what the options are.
The period immediately after any intensive phase carries elevated risk, and a plan that stops at discharge is not a plan. Continuing care is arranged before the intensive phase ends — ongoing therapy, medication management where it applies, and a specific arrangement for what happens on a bad week rather than a general encouragement to stay in touch.
Nothing here is medical advice. If you are physically dependent on alcohol or a benzodiazepine, do not stop without medical supervision — 911 in an emergency, or the free SAMHSA helpline on 1-800-662-HELP.
A programme that is right for everyone is a programme that has not decided anything. Ours has, and saying so in advance saves both sides a conversation that would end the same way.
Your professional life is intact and you intend to keep it that way. You want a clinical assessment rather than a sales conversation, and you can tell the difference. You are prepared to hear that the appropriate level of care is less intensive than you feared — or more.
You are looking for the cheapest available bed, or for a facility that will confirm a decision you have already made. You need acute psychiatric stabilisation, which is a hospital rather than a programme. You want a guarantee of an outcome — nobody honest sells one.
Most first calls come from a partner or a parent rather than the person themselves. That call is worth making: twenty-five minutes with a clinician gives you a realistic account of the options and of what is and is not within your control.
Every clinical claim on this site is traceable to a primary source, and the sources are named rather than gestured at. These are the ones this page rests on.
Peninsula Recovery Group is a treatment provider, not a directory. We describe our own programme; where we cite figures about treatment in general, the source is named above or on the page carrying the claim. Editorial policy →
No intake form. No email follow-up unless you ask for one. A clinician answers. Twenty-five minutes is enough to know.
Available 9am–9pm ET, seven days a week.
Facility data, where cited, comes from SAMHSA’s National Directory and state licensing boards. Statistics are cross-referenced against CDC WONDER, NIDA, and peer-reviewed research. Every medical claim is checked against primary sources before publication. Corrections are processed within 48 hours.
